Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure
- PMID: 25770240
- PMCID: PMC4578145
- DOI: 10.1152/ajpheart.00169.2015
Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure
Comment on
-
Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1078-85. doi: 10.1152/ajpheart.00679.2014. Epub 2015 Feb 20. Am J Physiol Heart Circ Physiol. 2015. PMID: 25713305 Free PMC article.
References
-
- Adamopoulos S, Coats AJ, Brunotte F, Arnolda L, Meyer T, Thompson CH, Dunn JF, Stratton J, Kemp GJ, Radda GK, Rajagopalan B. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 21: 1101–1106, 1993. - PubMed
-
- Alvarez-Guardia D, Palomer X, Coll T, Serrano L, Rodriguez-Calvo R, Davidson MM, Merlos M, El Kochairi I, Michalik L, Wahli W, Vazquez-Carrera M. PPARbeta/delta activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells. Biochim Biophys Acta 1811: 59–67, 2011. - PubMed
-
- Braunwald E. Heart failure. JACC Heart Fail 1: 1–20, 2013. - PubMed
-
- Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10: 1245–1250, 2004. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
